ロード中...

Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas

Proteasome inhibitors, such as bortezomib and carfilzomib, have shown efficacy in anti-cancer therapy in hematological diseases but not in solid cancers. Here, we found that liposarcomas (LPS) are susceptible to proteasome inhibition, and identified drugs that synergize with carfilzomib, such as sel...

詳細記述

保存先:
書誌詳細
出版年:Cell Mol Life Sci
主要な著者: Jeitany, Maya, Prabhu, Aishvaryaa, Dakle, Pushkar, Pathak, Elina, Madan, Vikas, Kanojia, Deepika, Mukundan, Vineeth, Jiang, Yan Yi, Landesman, Yosef, Tam, Wai Leong, Kappei, Dennis, Koeffler, H. Phillip
フォーマット: Artigo
言語:Inglês
出版事項: Springer International Publishing 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904719/
https://ncbi.nlm.nih.gov/pubmed/32851475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00018-020-03620-w
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!